Relevance of circulating tumor cells, extracellular nucleic acids, and exosomes in breast cancer Anne M. FrielClaire CorcoranLorraine O’Driscoll Review 15 June 2010 Pages: 613 - 625
Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis Melinda ProtaniMichael CooryJennifer H. Martin Review 23 June 2010 Pages: 627 - 635
Commentary on: “Effect of obesity on survival in women with breast cancer: systematic review and meta-analysis” (Melinda Protani, Michael Coory, Jennifer H. Martin) Pamela J. Goodwin Invited Commentary 14 August 2010 Pages: 637 - 640
Adult weight gain in relation to breast cancer risk by estrogen and progesterone receptor status: a meta-analysis Alina VrielingKatharina BuckJenny Chang-Claude Review 15 August 2010 Pages: 641 - 649
Nuclear IRS-1 predicts tamoxifen response in patients with early breast cancer Ilenia MigliaccioMeng-Fen WuAdrian V. Lee Preclinical study 19 November 2009 Pages: 651 - 660
Subtypes of familial breast tumours revealed by expression and copy number profiling Nic WaddellJeremy ArnoldGeorgia Chenevix-Trench Preclinical study 04 December 2009 Pages: 661 - 677
Transcriptional modulation of BCRP gene to reverse multidrug resistance by toremifene in breast adenocarcinoma cells Yuhua ZhangHuaiping WangGengyin Zhou Preclinical study 06 December 2009 Pages: 679 - 689
A gene expression signature that predicts the therapeutic response of the basal-like breast cancer to neoadjuvant chemotherapy Yiing LinShin LinRebecca L. Aft Preclinical study 06 December 2009 Pages: 691 - 699
Epithelial cell adhesion molecule (EpCAM) is overexpressed in breast cancer metastases Ashley CiminoMarc HalushkaPedram Argani Preclinical study 11 December 2009 Pages: 701 - 708
Inhibition of mammary tumor growth by estrogens: is there a specific role for estrogen receptors alpha and beta? Rocío SoldatiVictoria WargonClaudia Lanari Preclinical study 11 December 2009 Pages: 709 - 724
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients Balazs GyörffyAndras LanczkyZoltan Szallasi Preclinical study 18 December 2009 Pages: 725 - 731
Expression pattern of stromal cell-derived factor-1 chemokine in invasive breast cancer is correlated with estrogen receptor status and patient prognosis Takayuki KobayashiHitoshi TsudaOsamu Matsubara Preclinical study 18 December 2009 Pages: 733 - 745
Amplification of fibroblast growth factor receptor-1 in breast cancer and the effects of brivanib alaninate Christine Y. ShiangYuan QiLajos Pusztai Preclinical study 19 December 2009 Pages: 747 - 755
Gene amplification in ductal carcinoma in situ of the breast L. BurkhardtT. J. GrobA. Lebeau Preclinical study 22 December 2009 Pages: 757 - 765
Prognostic factors for skeletal complications from metastatic bone disease in breast cancer Janet E. BrownRichard J. CookRobert E. Coleman Clinical trial 24 June 2010 Pages: 767 - 779
Predicting skeletal complications in metastatic breast cancer raises challenges Catherine Van Poznak Invited Commentary 06 August 2010 Pages: 781 - 783
Quality of life in women with metastatic breast cancer during 9 months after randomization in the TEX trial (epirubicin and paclitaxel w/o capecitabine) Helene SvenssonZakaria EinbeigiYvonne Brandberg Clinical trial 03 August 2010 Pages: 785 - 793
Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients Teresa MeleDaniele GeneraliAlfredo Berruti Clinical trial 03 August 2010 Pages: 795 - 804
Bone mineral density loss during adjuvant chemotherapy in pre-menopausal women with early breast cancer: is it dependent on oestrogen deficiency? David A. CameronSharon DouglasRichard A. Anderson Clinical trial 05 August 2010 Pages: 805 - 814
Estrogen deficiency and bone loss in women with breast cancer Charles L. Shapiro Invited Commentary 10 August 2010 Pages: 815 - 818
Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study Brenna C. McDonaldSusan K. ConroyAndrew J. Saykin Clinical trial 06 August 2010 Pages: 819 - 828
Pre-surgical study of the biological effects of the selective cyclo-oxygenase-2 inhibitor celecoxib in patients with primary breast cancer Lesley-Ann MartinGiles L. S. DaviesMitch Dowsett Clinical trial 10 August 2010 Pages: 829 - 836
Phase II study evaluating the efficacy and safety of sagopilone (ZK-EPO) in patients with metastatic breast cancer that has progressed following chemotherapy Phuong K. MorrowStephen DiversLinda T. Vahdat Clinical trial 10 August 2010 Pages: 837 - 842
Common genetic variation of insulin-like growth factor-binding protein 1 (IGFBP-1), IGFBP-3, and acid labile subunit in relation to serum IGF-I levels and mammographic density Cornelia W. TaverneMartijn VerheusCarla H. van Gils Epidemiology 14 February 2010 Pages: 843 - 855
TGFB1 T29C polymorphism and breast cancer risk: a meta-analysis based on 10,417 cases and 11,455 controls Dongying GuLuhong ZhuangJinfei Chen Epidemiology 16 February 2010 Pages: 857 - 861
TGF-β1 29T/C polymorphism and breast cancer risk: a meta-analysis involving 25,996 subjects Yongsheng HuangBinghui LiLong Yu Epidemiology 21 February 2010 Pages: 863 - 868
Adipocytokine resistin and breast cancer risk Chien-An SunMei-Hsuan WuJyh-Cherng Yu Epidemiology 23 February 2010 Pages: 869 - 876
NAT2 polymorphisms combining with smoking associated with breast cancer susceptibility: a meta-analysis Jian ZhangLi-Xin QiuXi-Chun Hu Epidemiology 24 February 2010 Pages: 877 - 883
Genetic polymorphisms in folate and alcohol metabolism and breast cancer risk: a case–control study in Thai women Suleeporn SangrajrangYasunori SatoTeruhiko Yoshida Epidemiology 24 February 2010 Pages: 885 - 893
Nipple discharge: is its significance as a risk factor for breast cancer fully understood? Observational study including 915 consecutive patients who underwent selective duct excision Isacco MontroniDonatella SantiniMario Taffurelli Brief Report 31 March 2010 Pages: 895 - 900
Copy number variations are not modifiers of phenotypic expression in a pair of identical twins carrying a BRCA1 mutation A. LasaT. Ramón y CajalM. Baiget Brief Report 06 April 2010 Pages: 901 - 905
Mouse mammary tumor-like virus and human breast cancer Wendy K. GlennBrian SalmonsNoel J. Whitaker Letter to the Editor 10 July 2010 Pages: 907 - 909
The role of RACK1 as an independent prognostic indicator in human breast cancer Sara Al-ReefyKefah Mokbel Letter to the Editor 15 July 2010 Pages: 911 - 912